BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17367882)

  • 1. Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: impact on long-term prognosis.
    Lavi S; Kapeliovich M; Gruberg L; Roguin A; Boulos M; Grenadier E; Amikam S; Markiewicz W; Beyar R; Hammerman H
    Int J Cardiol; 2008 Jan; 123(2):117-22. PubMed ID: 17367882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention.
    Straumann E; Kurz DJ; Muntwyler J; Stettler I; Furrer M; Naegeli B; Frielingsdorf J; Schuiki E; Mury R; Bertel O; Spinas GA
    Am Heart J; 2005 Nov; 150(5):1000-6. PubMed ID: 16290985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.
    Timmer JR; van der Horst IC; Ottervanger JP; Henriques JP; Hoorntje JC; de Boer MJ; Suryapranata H; Zijlstra F;
    Am Heart J; 2004 Sep; 148(3):399-404. PubMed ID: 15389225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era.
    Ishihara M; Kagawa E; Inoue I; Kawagoe T; Shimatani Y; Kurisu S; Nakama Y; Maruhashi T; Ookawa K; Dai K; Aokage Y
    Am J Cardiol; 2007 Jun; 99(12):1674-9. PubMed ID: 17560874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Gasior M; Stasik-Pres G; Pres D; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2007 Sep; 65(9):1031-8; discussion 1039-40. PubMed ID: 17975750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.
    Kosiborod M; Rathore SS; Inzucchi SE; Masoudi FA; Wang Y; Havranek EP; Krumholz HM
    Circulation; 2005 Jun; 111(23):3078-86. PubMed ID: 15939812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era.
    Ishihara M; Kojima S; Sakamoto T; Asada Y; Tei C; Kimura K; Miyazaki S; Sonoda M; Tsuchihashi K; Yamagishi M; Ikeda Y; Shirai M; Hiraoka H; Inoue T; Saito F; Ogawa H;
    Am Heart J; 2005 Oct; 150(4):814-20. PubMed ID: 16209987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of admission glucose level on long-term prognosis in patients with acute coronary syndrome].
    Macín SM; Perna ER; Coronel ML; Kriskovich JO; Bayol PA; Franciosi VA; Riera-Stival JL; González-Arjol B; Badaracco JR
    Rev Esp Cardiol; 2006 Dec; 59(12):1268-75. PubMed ID: 17194422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose normalization and outcomes in patients with acute myocardial infarction.
    Kosiborod M; Inzucchi SE; Krumholz HM; Masoudi FA; Goyal A; Xiao L; Jones PG; Fiske S; Spertus JA
    Arch Intern Med; 2009 Mar; 169(5):438-46. PubMed ID: 19273773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
    Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
    Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
    Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
    Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus.
    Porter A; Assali AR; Zahalka A; Iakobishvili Z; Brosh D; Lev EI; Mager A; Battler A; Kornowski R; Hasdai D
    Am Heart J; 2008 Feb; 155(2):284-9. PubMed ID: 18215598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study.
    Zhang Q; Zhang RY; Qiu JP; Jin HG; Zhang JF; Wang XL; Jiang L; Liao ML; Hu J; Ding FH; Zhang JS; Shen WF
    Chin Med J (Engl); 2009 Mar; 122(6):636-42. PubMed ID: 19323926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implication of hyperglycemia in myocardial infarction and primary angioplasty.
    Worthley MI; Shrive FM; Anderson TJ; Traboulsi M
    Am J Med; 2007 Jul; 120(7):643.e1-7. PubMed ID: 17602940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
    Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes.
    Lazzeri C; Valente S; Chiostri M; Picariello C; Gensini GF
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):419-23. PubMed ID: 20517158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.